Last update:

Oncology & Cancer news

Oncology & Cancer

Tumor bacteria linked to immunotherapy resistance in head and neck cancer

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others.

Medications

Breast cancer drug boosts leukemia treatment: Unexpected duo shows promise in overcoming resistance

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.

Oncology & Cancer

Study finds a better way to screen for breast cancer

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients' risk, rather than annual mammograms, can lower the chance of more advanced cancers, while still safely match ...

Oncology & Cancer

How stomach cancer learns to grow on its own

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its high prevalence, it has received far less molecular attention than colorectal cancer, which is more ...

Oncology & Cancer

Stiffer colon could signal risk of early-onset colorectal cancer

Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of early-onset colorectal cancer (CRC), a study co-led by UT Southwestern Medical Center researchers suggests. ...

Oncology & Cancer

Inflammation fuels one of the most aggressive forms of lung cancer

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%. Despite this poor prognosis, SCLC is initially highly responsive to chemotherapy. However, patients ...

Oncology & Cancer

Protein MCL1 links cancer cell survival and energy metabolism

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides fundamental insights into cancer biology. Published in Nature Communications, the study shows for ...

Oncology & Cancer

How brain tumor cells influence neurons and vice versa

Gliomas are cancers that originate directly in the brain, instead of spreading to the brain from other parts of the body. These cancers cannot be cured with conventional cancer treatments, as they spread into healthy brain ...

Oncology & Cancer

Making cancer screening more accessible to underserved groups

New research from the University of Aberdeen and the Grampian Regional Equality Council (GREC) has outlined ways to make cancer screening services more accessible to people who may be underserved by the health care system. ...

Oncology & Cancer

Mobile DNA elements reveal their role in lung cancer progression

Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) researchers, identified key factors that drive tumor evolution and influence outcomes. Overall, ...

Oncology & Cancer

A paper-based technology could transform cancer drug testing

Researchers at New York University Abu Dhabi (NYUAD) have developed Spheromatrix, a simple and low-cost technology that enables tumor models to be grown, frozen, and stored for future use in cancer drug testing.

Oncology & Cancer

Cell-free DNA could detect adverse events from immunotherapy

A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns Hopkins Kimmel Cancer ...

Oncology & Cancer

Off-the-shelf immunotherapy offers new hope for toughest myeloma

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma—one of the most ...

Oncology & Cancer

FDA approves expanded indication for Jaypirca

The U.S. Food and Drug Administration has approved an expanded indication for Eli Lilly's Jaypirca (pirtobrutinib), the first and only noncovalent Bruton tyrosine kinase (BTK) inhibitor for adults with relapsed or refractory ...

Oncology & Cancer

New gene-mapping method unlocks hidden drivers of cancer

University of South Australia scientists have developed a powerful new way to uncover the genetic interactions that fuel cancer progression, paving the way for earlier and more precise treatments.